Concentra (CON) Q3 2026 earnings review
Concentra treats more workers, and it raises its yearly plan
Concentra's clinics for injured and newly hired workers saw more patients and kept a bigger share of sales as profit. Revenue rose 9%, and profit before interest, tax and depreciation, excluding one-offs, climbed 18%. New chief executive Matt DiCanio raised the yearly plan, yet by our math it has fourth-quarter growth slowing to about 6%.
| Revenue | $622.1M +8.6% from a year ago |
|---|---|
| Profit per share | $0.52 +36.8% from $0.38 a year ago |
| Clinic visits per day | 58,312 +4.9% from a year ago |
| Full-year revenue outlook | Raised $20M middle of the range: 9.5% growth |
⚖️ Verdict: 🟢 Bullish
The story got better because hiring-related visits sped up, and DiCanio said that has historically led to more injury visits. Results also beat what the August plan implied, so that plan was cautious. One caution: onsite clinic growth fell to 10%, and the Justice Department now investigates Concentra's own billing.
The question now is whether the hiring jump lasts. If it does, injury visits should follow and the fourth-quarter plan looks low; if not, growth drifts back toward low single-digit visit gains. Employer-services visits in the fourth quarter will tell.
🐂 Bull Case
Hiring Checks and Injury Visits Both Sped Up
Concentra runs 639 clinics where employers send injured staff for treatment and new hires for drug tests and physicals. Chief executive Matt DiCanio credited "favorable labor market conditions in many of the blue collar sectors we serve, and continued market share gains".
Both kinds of visits sped up this quarter. The hiring side, which Concentra calls employer services, grew fastest, while DiCanio said "stronger initial injury visit volumes" lifted workers' compensation, its name for injury care.
- Employer services visits per day: up 5.8%, after 1.8% in the second quarter
- Workers' compensation visits per day: up 4.2%, after 3.7%
- All clinic visits: 58,312 a day, up 4.9%
This matters because DiCanio said a pickup in hiring checks has historically led to more injury visits later. Finance chief Tanner Newton called data-center building a "relatively small and immaterial part of the overall book of business". The risk view holds that a blue-collar hiring slowdown would hit these checks first.
What to watch: employer services visit growth in the fourth-quarter results early next year. DiCanio called it "an early indicator of economic activity", so a second strong quarter would point to rising injury visits in 2027.
Clinic Costs Took a Smaller Share of Revenue
Cost of services is what Concentra spends to run its clinics, mostly staff pay. It took 68.6% of revenue, down 2.2 percentage points from a year ago, and the company credited "increased staffing efficiencies across our centers".
Head-office costs moved the other way. General and administrative spending reached 9.8% of revenue, from 9.2%, because Concentra hired staff to run alone after leaving its former parent, Select Medical. Finance chief Tanner Newton described part of it as "a few additional expenses I would characterize as more onetime in nature".
What to watch: head-office costs as a share of revenue in the fourth quarter. Newton expects a level between the second and third quarters, so a figure above 9.8% would mean the extra costs are lasting.
Concentra Cut Debt and Bought Back Shares
Net leverage compares Concentra's debt, minus cash, with a year of profit before interest, tax and depreciation. It fell to 2.90 times, below the goal of 3.0 that the clinic operator had set for December.
During the quarter Concentra repaid $52.4 million of its term loan. It also bought back 1.0 million shares, all from board chairman Robert Ortenzio in a private deal. S&P Global then lifted its credit rating to BB from BB-.
Chief executive Matt DiCanio said Concentra "strengthened the balance sheet and returned capital to shareholders". The board approved a new $250 million buyback, and finance chief Tanner Newton said lower debt lets the group "elevate share repurchases" alongside loan payments.
What to watch: net leverage at year-end against Newton's target of 2.5 times within 12 months. A ratio that stops falling would mean buybacks and clinic purchases are taking the cash that paid down debt.
Concentra Raised Its Yearly Plan a Third Time
Each quarter Concentra updates its plan for the full year. By our math, the August plan implied third-quarter revenue of about $592–618 million. The clinic operator delivered $622 million, above what its own plan pointed to.
Profit before interest, tax and depreciation, excluding one-offs, came in about 11% above the middle of what that plan implied. Concentra then lifted the middle of its yearly profit range by $17.5 million, its third increase this year.
The gap says the August plan was cautious, but it does not prove demand will stay this strong. By our math, the new plan still has fourth-quarter revenue growth at about 6%, against 9% in the third quarter.
What to watch: fourth-quarter revenue, reported early next year, against that 6% pace. A result well above it would mean the new plan carries the same caution as the August one.
🐻 Bear Case
Onsite Clinic Growth Slowed to 10%
Concentra also runs 423 clinics inside employers' workplaces, called onsite health clinics. In June 2025 it bought Pivot Onsite Innovations, which ran more than 240 of them. Chief executive Matt DiCanio said onsite "fundamentals remain strong", and the positive view held that these clinics had become a second source of growth.
This was the first quarter with Pivot in both years, and onsite revenue rose only 10%, to $38.4 million. Excluding Pivot, the unit had grown 28% in the second quarter. Finance chief Tanner Newton blamed Pivot's "relatively modest year over year growth".
This matters because Concentra keeps buying clinic groups, and by Newton's account Pivot now trails the rest of the onsite business. The occupational-health group does not report the unit's profit, so readers cannot judge what the purchase earns.
What to watch: onsite revenue growth in the fourth quarter, the second with Pivot in both years. Another reading near 10% would mean onsite grows no faster than the company as a whole.
Justice Department Now Investigates Concentra Directly
Officials have long examined how Concentra and its former parent, Select Medical, billed for physical therapy. Until now, the federal review under the False Claims Act targeted Select. On September 9 the Justice Department told Concentra it is "the subject of a separate investigation under the False Claims Act".
The step adds to two California cases over physical-therapy claims: a state fraud probe and a whistleblower lawsuit. The occupational-health group said it cannot predict the outcome and disclosed no reserve.
This matters because physical therapy is part of injury care, Concentra's largest business, so a settlement would hit its main source of revenue.
What to watch: the annual report due early next year, for any reserve or settlement talks. A reserve would turn an open legal question into a cost with a number.
Free Cash Flow Fell Despite Higher Profit
Free cash flow is the cash left after running the clinics and paying for equipment and new sites. It fell 20% from a year ago, to $32.2 million. Net income, by contrast, climbed 36%.
Finance chief Tanner Newton blamed "working capital timing and higher cash tax payments". Concentra paid $31.6 million in tax, against $3.6 million a year earlier, because certain tax benefits from the prior year ran out, Newton said.
Those causes may be temporary, but the full-year plan points the same way. Concentra raised its profit range yet kept its cash flow range unchanged. By our math, that leaves about $67 million for the fourth quarter, roughly a third below a year earlier.
What to watch: fourth-quarter free cash flow against that $67 million. A result near it would mean higher tax bills now absorb a lasting share of the profit gains.
Risks this quarter didn't answer
Several standing concerns got no decisive new numbers in these results. Each item below names the reading that would move it, and roughly when that reading should arrive.
- 2027 injury-care prices: about 20 to 25 states publish their fee schedules, the state-set price lists, within two months, finance chief Tanner Newton said; a cut in a large state would hurt.
- New York: the state kept its proposed price rise for injury visits but set no start date; a date would let Concentra decide whether to enter.
- Visit mix: more physicals lifted employer prices this quarter, and chief executive Matt DiCanio said the mix shows no consistent pattern; next quarter's price per visit will show it.
- Leadership: DiCanio and Newton took their new roles on November 1; their first full-year plan, due early 2027, is the first test.
- Data-breach lawsuits over a transcription vendor: no change; Concentra expects its insurer to cover them.
👓 Other Themes
Wage Growth Matches the Price Rises Concentra Expects
Chief executive Matt DiCanio said wages are rising about 3% a year and staff turnover is stable. Concentra plans its usual January price rise for employers, near its long-term 3% pace. For injury care, where states set prices, DiCanio has "no reason to expect aggregate workers' compensation rate growth to differ materially from our long term expectations".
💲 Other KPIs
The average price per clinic visit rose 3.3% from a year ago, slower than the 4.6% of the second quarter. Growth has stayed in a narrow band for five quarters. Higher state price lists for injury care drove most of it, while more physicals pushed the employer side up 4.0%.
Money owed by customers and insurers climbed 24% since December, ahead of sales. By our math, it equals about 47 days of revenue, against 44 days at year-end. Concentra tied the build-up to higher revenue per day and called credit losses rare, because insurers and employer programs pay most bills.
Interest costs fell 12.3% from a year ago. Concentra repaid its revolving credit line and part of its term loan, and the loan's rate dropped a quarter point in August as debt shrank against profit. Interest now takes 4.0% of revenue, against 5.0% a year earlier.
🔮 Guidance
Raised. The plan now has full-year revenue rising about 9.5% at the middle of the range. By our math, that leaves about 6% growth for the fourth quarter. Concentra finished 2025 above its final range, so a cautious remainder fits its record. It is the third increase this year: +$25M, +$25M, then +$20M at the middle.
Raised. Profit before interest, tax and depreciation, excluding one-offs, now rises about 17.5% for the year in the plan. By our math, the fourth quarter then needs only about 11% growth, at a margin near 18.5%. Last year's fourth quarter had the weakest margin of 2025. Moves at the middle this year: +$10M, +$20M, then +$17.5M.
Unchanged. The plan still calls for $220–240 million of free cash flow, even though the profit range went up. By our math, that leaves about $67 million for the fourth quarter. That would sit roughly a third below the same quarter of 2025. Finance chief Tanner Newton tied the third-quarter decline to tax payments and working-capital timing.
Unchanged. Concentra still plans $70–80 million of spending on clinics, equipment and technology, net of building sales. By our math, that leaves $25–35 million for the fourth quarter. The spending covers three new clinics that opened or will open after September, chief executive Matt DiCanio said.
❓ Key Questions
How fast did onsite clinics grow without Pivot?
Onsite growth dropped to 10% once Pivot sat in both years. A figure for the older onsite clinics would show whether Pivot alone slowed or the whole unit did.
What profit do the onsite clinics earn?
Concentra keeps buying onsite clinics but does not report the unit's profit. Without it, readers cannot tell whether the Pivot purchase pays for itself.
What could the federal billing investigation cost?
The Justice Department now investigates Concentra directly over physical-therapy billing. Readers need the scope, the years covered and whether the company has set aside any reserve.
How much of the cash shortfall reverses next quarter?
Free cash flow fell 20% on higher taxes and working-capital timing. The full-year plan leaves only about $67 million for the fourth quarter, so the split between timing and lasting cost matters.
Which large states change injury-care prices in 2027?
About 20 to 25 states publish new price lists by January. Texas and California each hold about 16% of Concentra's centers, so their decisions shape 2027 revenue.